Introduction To propose an improved U-Net-based segmentation model for colorectal polyp segmentation, aiming to address the challenges of variable lesion morphology, ambiguous boundaries, complex background interference, and insufficient cross-level feature fusion in endoscopic images [5,12].

Methods An improved network termed MCA-UNet was developed based on U-Net [5]. The model incorporates a multi-scale context convolution block (MCCB) to enhance multi-scale feature extraction and an attention-guided feature fusion module (AGFF) to optimize skip-feature selection and fusion in the decoder. Experiments were conducted on publicly available colorectal polyp image datasets, including Kvasir-SEG and CVC-ClinicDB [13-15]. Four models, including U-Net, U-Net+MCCB, U-Net+AGFF, and MCA-UNet, were compared, and all models were trained for 100 epochs. Dice, intersection over union (IoU), and mean absolute error (MAE) were used as the main evaluation metrics [20].

Results On the mixed validation set, the Dice scores of U-Net, U-Net+MCCB, U-Net+AGFF, and MCA-UNet were 0.742, 0.771, 0.754, and 0.783, respectively; the corresponding IoU values were 0.603, 0.635, 0.618, and 0.649; and the MAE values were 0.102, 0.090, 0.097, and 0.086. Compared with the baseline U-Net, MCA-UNet improved Dice and IoU by 5.53% and 7.63%, respectively, while reducing MAE by 15.69%. Comparisons on the Kvasir-SEG and CVC-ClinicDB validation subsets further demonstrated the more stable performance of the proposed model.

Conclusion By jointly integrating multi-scale contextual modeling and attention-guided feature fusion, MCA-UNet effectively improves the accuracy and robustness of colorectal polyp segmentation and may provide useful support for intelligent endoscopic image analysis [12,17,18].

The authors have declared no competing interest.

No specific funding was received for this study.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The datasets used in this study are publicly available, including Kvasir-SEG and CVC-ClinicDB

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes